Sichuan Kelun Pharmaceutical Co., Ltd. (002422.SZ)
CNY 30.51
(-0.46%)
CNY 30.51
(-0.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 5.47 Billion | 3.12 Billion | 2.84 Billion | 2.21 Billion | 2.21 Billion | 2.95 Billion |
| Net Income | 2.45 Billion | 1.7 Billion | 868.11 Million | 791.47 Million | 1.02 Billion | 1.26 Billion |
| Depreciation & Amortization | 1.25 Billion | 1.17 Billion | 1.21 Billion | 1.15 Billion | 1.07 Billion | 986.95 Million |
| Deferred income taxes | 273.89 Million | -25.08 Million | -35.62 Million | -75.49 Million | -71.33 Million | -158.76 Million |
| Stock-based compensation | 215.53 Million | - | - | - | 5.65 Million | - |
| Change in working capital | 975.5 Million | -167.98 Million | 332.01 Million | -542.77 Million | -554.13 Million | -103.52 Million |
| Other non-cash items | 2.26 Billion | 369.25 Million | 428.72 Million | 815.88 Million | 744.6 Million | 802.59 Million |
| Investing Cash Flow | -1.01 Billion | -856.58 Million | -1.52 Billion | -905.28 Million | -1.35 Billion | -958.99 Million |
| Investments in PPE | -1.76 Billion | -896.02 Million | -990.56 Million | -1.23 Billion | -1.33 Billion | -1.32 Billion |
| Acquisitions | 2.57 Billion | 5.93 Million | 7.98 Million | 623.5 Million | 34 Million | 11.58 Million |
| Investment purchases | -7.61 Billion | -5.1 Billion | -1.7 Billion | -1.73 Billion | -318.54 Million | -2.29 Million |
| Sales/Maturities of investments | 5.81 Billion | 5.12 Billion | 1.19 Billion | 1.43 Billion | 55.05 Million | 53.88 Million |
| Other Investing Activities | -10.13 Million | 12.71 Million | -30.13 Million | 6.08 Million | 201.18 Million | 307 Million |
| Financing Cash Flow | -4.54 Billion | -407.26 Million | -1.27 Billion | -722.1 Million | -467.98 Million | -1.38 Billion |
| Debt repayment | -3.23 Billion | -10.62 Billion | -9.43 Billion | -10.98 Billion | -5.34 Billion | -10.92 Billion |
| Dividends payments | -899.76 Million | -597.78 Million | -450.04 Million | -602.18 Million | -300.05 Million | -983.94 Million |
| Common Stock Repurchased | -1.39 Million | -151.69 Million | -200.01 Million | -135.11 Million | -272.71 Million | -100.02 Million |
| Common Stock Issuance | 15.28 Million | 45.24 Million | 200.01 Million | 135.11 Million | 272.71 Million | 16.22 Million |
| Other Financing Activities | -373.17 Million | 11.35 Billion | 9.15 Billion | 11.39 Billion | 5.72 Billion | 10.52 Billion |
| Accounts receivables | 1.08 Billion | -893.91 Million | 625.7 Million | 67.73 Million | -764.39 Million | -267.6 Million |
| Accounts payables | 313.96 Million | 580.76 Million | -365.48 Million | -405.44 Million | 734.36 Million | 861.79 Million |
| Inventory | -645.26 Million | 170.26 Million | 107.41 Million | -129.55 Million | -452.76 Million | -538.94 Million |
| Other working capital | 218.55 Million | -25.08 Million | -35.62 Million | -75.49 Million | -71.33 Million | 435.41 Million |
| Cash at beginning of period | 4.72 Billion | 2.8 Billion | 2.76 Billion | 2.19 Billion | 1.8 Billion | 1.19 Billion |
| Cash at end of period | 4.67 Billion | 4.67 Billion | 2.8 Billion | 2.76 Billion | 2.19 Billion | 1.8 Billion |
| Capital Expenditure | -1.76 Billion | -896.02 Million | -990.56 Million | -1.23 Billion | -1.33 Billion | -1.32 Billion |
| Effect of forex changes on cash | 5.19 Million | 7.93 Million | -8.26 Million | -28.2 Million | 2.21 Million | -303.71 Thousand |
| Net cash flow / Change in cash | -53.42 Million | 1.87 Billion | 38.3 Million | 563.78 Million | 391.63 Million | 612.31 Million |
| Free Cash Flow | 3.7 Billion | 2.23 Billion | 1.85 Billion | 988.49 Million | 885.7 Million | 1.62 Billion |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 670.81 Million | 773.92 Million | 1.02 Billion | 2.45 Billion | 492.78 Million | 561.12 Million |
| Depreciation & Amortization | - | 313.57 Million | 313.57 Million | 1.25 Billion | 315.51 Million | -615.22 Million |
| Deferred income taxes | - | - | - | 273.89 Million | - | 1.59 Billion |
| Stock-based compensation | - | 98.62 Million | - | 215.53 Million | 215.53 Million | -113.96 Million |
| Change in working capital | - | 206.6 Million | - | 975.5 Million | 661.54 Million | -908.84 Million |
| Other non-cash items | 150.02 Million | 887.62 Million | 271.35 Million | 2.26 Billion | 916.09 Million | 319.91 Million |
| Investing Cash Flow | -1.3 Billion | -830.8 Million | 652.6 Million | -1.01 Billion | -1.62 Billion | 206.66 Million |
| Investments in PPE | -374.77 Million | -370.44 Million | -537.21 Million | -1.76 Billion | -666.27 Million | -427.94 Million |
| Acquisitions | 6.49 Million | 555.02 Million | 2.59 Million | 2.57 Billion | -63.17 Million | 2.55 Billion |
| Investment purchases | -6.22 Billion | -2.86 Billion | -565 Million | -7.61 Billion | -1.89 Billion | -1.34 Billion |
| Sales/Maturities of investments | 5.29 Billion | 2.37 Billion | 1.75 Billion | 5.81 Billion | 1 Billion | 1.98 Billion |
| Other Investing Activities | - | -460.36 Million | 1.2 Billion | -10.13 Million | -10.13 Million | -2.55 Billion |
| Financing Cash Flow | -491.32 Million | -575.25 Million | -308.78 Million | -4.54 Billion | -309.79 Million | 550.41 Million |
| Debt repayment | -447.87 Million | -471.65 Million | -228.88 Million | -3.23 Billion | -334.78 Million | -1.99 Billion |
| Dividends payments | - | -1.3 Billion | -35.77 Million | -899.76 Million | -899.76 Million | -51.73 Million |
| Common Stock Repurchased | - | -64.39 Million | - | -1.39 Million | -1.39 Million | -1.32 Billion |
| Common Stock Issuance | - | - | - | 15.28 Million | 15.28 Million | 1.32 Billion |
| Other Financing Activities | -43.44 Million | 461.26 Million | -79.9 Million | -373.17 Million | 963.45 Million | 2.59 Billion |
| Accounts receivables | - | -455.67 Million | - | 1.08 Billion | 1.08 Billion | -891.88 Million |
| Accounts payables | - | - | - | 313.96 Million | - | - |
| Inventory | - | 564.33 Million | - | -645.26 Million | -645.26 Million | -16.95 Million |
| Other working capital | - | 97.94 Million | - | 218.55 Million | 218.55 Million | -113.96 Million |
| Cash at beginning of period | 6.1 Billion | 6.23 Billion | 4.67 Billion | 4.72 Billion | 6.14 Billion | 3.84 Billion |
| Cash at end of period | 5.12 Billion | 6.07 Billion | 6.28 Billion | 4.67 Billion | 4.67 Billion | 5.43 Billion |
| Capital Expenditure | -374.77 Million | -370.44 Million | -537.21 Million | -1.76 Billion | -666.27 Million | -427.94 Million |
| Effect of forex changes on cash | - | -3.33 Million | 1.81 Million | 5.19 Million | 3.95 Million | -9.43 Million |
| Net cash flow / Change in cash | -980.75 Million | -155.46 Million | 1.61 Billion | -53.42 Million | -1.46 Billion | 1.58 Billion |
| Free Cash Flow | 446.06 Million | 977.52 Million | 760.32 Million | 3.7 Billion | 427.08 Million | 413.49 Million |
OVS
PORF
ALFLO
CART
004060
TREL